• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2010 HAYES, Inc. Propofol for moderate sedation during colonoscopy
2010 HAYES, Inc. Screening, brief intervention, and referral to treatment (SBIRT) for alcohol misuse
2010 HAYES, Inc. Selective serotonin reuptake inhibitors in the treatment of post traumatic stress disorder
2010 HAYES, Inc. Total ankle replacement
2010 HAYES, Inc. Transcutaneous bilirubin measurement
2010 HAYES, Inc. Ultraviolet B phototherapy for vitiligo
2010 HAYES, Inc. BRAF p.Val600Glu (V600E) testing for assessment of treatment options in metastatic colorectal cancer
2010 HAYES, Inc. Catecholaminergic polymorphic ventricular tachycardia (CPVT)
2010 HAYES, Inc. Celiac disease
2010 HAYES, Inc. Early-onset familial Alzheimers disease (EOFAD; AD1, AD3, and AD4 )
2010 HAYES, Inc. MECP2 testing for Rett Syndrome and other disorders
2010 HAYES, Inc. PTEN Hamartoma Tumor Syndrome (PHTS)
2010 HAYES, Inc. UGT1A1 Sequence Variant Testing for Predicting Response to Irinotecan Therapy in Colorectal Cancer
2010 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bariatric surgery in diabetic type 2 patients with CMI at or above 30 kg/m2]
2010 Institute for Clinical Effectiveness and Health Policy (IECS) Electrical stimulation for the treatment of headaches
2010 Institute for Clinical Effectiveness and Health Policy (IECS) Tocilizumab for rheumatoid arthritis
2010 Institute for Clinical Effectiveness and Health Policy (IECS) Digital dermoscopy in the diagnosis of melanoma
2010 Institute for Clinical Effectiveness and Health Policy (IECS) Citoreductive Surgery + Hypertermic Intraperitoneal Quimiotherapy for peritoneal carcinomatosis
2010 Institute for Clinical Effectiveness and Health Policy (IECS) Pandemic Influenza A Vaccine (H1N1)
2010 Institute for Clinical Effectiveness and Health Policy (IECS) Clofarabine for the treatment of adult leukemia and lymphoma
2010 Institute for Clinical Effectiveness and Health Policy (IECS) Chemoembolization of hepatocellular carcinoma with drug eluting beads (DC Beads)
2010 Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous aortic valve replacement for aortic stenosis]
2010 Medical Advisory Secretariat (MAS) Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis
2010 Medical Advisory Secretariat (MAS) Balloon kyphoplasty for treatment of painful osteoporotic vertebral compression fractures : an evidence update
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation Part 3b: Retrospective cohort study (with/without phase III rehabilitation) - application of the evaluation plan]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Classification of disease severity for neuro- and trauma rehabilitation Part 3: Status quo in Austria]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Impact of HTA-research in Austria for the health care system. Part 1: Overview - Update]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Screening for colorectal cancer Part 1: Screening tests and project design]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hyperthermia]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Screening for colorectal cancer Part 2: Health Economic evaluations and development of costs]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [High-intensity focussed ultrasound (HIFU) for the treatment of prostate cancer]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Artificial disc replacement]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Laser angioplasty of coronary arteries]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Radionuclide therapy - 90Yttrium and 177Lutetium somatostatin analogues for the treatment of inoperable neuroendocrine tumors]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous repair of mitral regurgitation with the MitraClip]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures - 1st Update 2010]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Stent-grafting of the ascending aorta - 2nd Update 2010]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Cardiac contractility modulation for heart failure- 2nd Update 2010]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous aortic valve replacement - 2nd Update 2010]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Endobronchial valve implantation for emphysema - 2nd Update 2010]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Plerixafor (Mozobil) for autologous stem cell transplantation in patients with lymphoma and multiple myeloma
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Lapatinib ditosylate (Tyverb/Tykerb) as first-line therapy for the treatment of advanced/metastatic breast cancer
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bendamustine (Ribomustin/Treanda/ Levact) for indolent non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukaemia (CLL) and multiple myeloma
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Panitumumab (Vectibix) for the first-line treatment of metastatic colorectal cancer
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Trastuzumab (Herceptin) in addition to standard chemotherapy as first-line therapy for advanced gastric cancer
2010 Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of nitrous oxide 50% mixed with oxygen in the use as inhalation analgesic during labor]
2010 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Economic evaluation of a pneumococcal vaccination program in a pediatric population]
2010 HTA Database, Centre for Reviews and Dissemination, University of York (CRD) The role of molecular-targeted agents involving maintenance therapy for non-small-cell lung cancer (Protocol for a systematic review)
2010 Health Information and Quality Authority (HIQA) Economic guidelines for the conduct and appraisal of health technology assessments in Ireland
2010 Agency for Healthcare Research and Quality (AHRQ) Effectiveness of recombinant human Growth Hormone (rhGH) in the treatment of patients with cystic fibrosis.
2010 Medical Services Advisory Committee (MSAC) Assessment of liver iron by R2 - Medical Resonance Imaging (MRI) data analysis
2010 Medical Services Advisory Committee (MSAC) Middle ear implant for sensorineural, conductive and mixed hearing losses
2010 Medical Services Advisory Committee (MSAC) Radiofrequency ablation for barrett's oesophagus with dysplasia
2010 VA Technology Assessment Program (VATAP) Treatments for metastatic castrate-resistant prostate cancer
2010 VA Technology Assessment Program (VATAP) Ultrafiltration for decompensated heart failure
2010 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Interferon-gamma release assays (IGRAs) for diagnosis of latent tuberculosis infection and active tuberculosis]
2010 Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic-based strategies for smoking cessation
2010 Medical Advisory Secretariat (MAS) Positron emission tomography (PET) for the assessment of myocardial viability
2010 Medical Advisory Secretariat (MAS) Primary angioplasty and thrombolysis for the treatment of acute ST-segment elevated myocardial infarction : an evidence update
2010 Medical Advisory Secretariat (MAS) Magnetic resonance imaging (MRI) for the assessment of myocardial viability
2010 Medical Advisory Secretariat (MAS) Stenting for peripheral disease of the lower extremities
2010 Medical Advisory Secretariat (MAS) Endovascular repair of abdominal aortic aneurysms in low surgical risk patients
2010 NIHR Health Technology Assessment programme Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections.
2010 NIHR Health Technology Assessment programme Evaluation of triage methods used to select patients with suspected pandemic influenza for hospital admission: cohort study
2010 NIHR Health Technology Assessment programme Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion- adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
2010 NIHR Health Technology Assessment programme Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
2010 Institute for Clinical Effectiveness and Health Policy (IECS) [Sperm DNA fragmentation and annexin column use in assisted reproductive treatments]
2010 Institute for Clinical Effectiveness and Health Policy (IECS) [Gefitinib for the treatment of lung cancer]
2010 Institute for Clinical Effectiveness and Health Policy (IECS) [Levonorgestrel-releasing intrauterine device (IUD) for patients with hypermenorrhea]
2010 Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of serum-free light chain measurement in monoclonal gammopathy]
2010 Institute for Clinical Effectiveness and Health Policy (IECS) [Positron emission tomography (PET): diagnostic usefulness and indications]
2010 Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of detecting rearrangement of FIP1L1-PDGFRA in patients with primary hypereosinophilic syndrome]
2010 NIHR Horizon Scanning Centre (NIHR HSC) Cx501 for cutaneous lesions associated with recessive dystrophic epidermolysis bullosa
2010 NIHR Horizon Scanning Centre (NIHR HSC) Dabigatran etexilate (Pradaxa) for secondary prevention of venous thromboembolism (VTE)
2010 NIHR Horizon Scanning Centre (NIHR HSC) Dienogest (Visabelle) for recurrent endometriosis - second or third line
2010 NIHR Horizon Scanning Centre (NIHR HSC) Duloxetine (Cymbalta) for chronic somatic pain
2010 NIHR Horizon Scanning Centre (NIHR HSC) Ivabradine (Procoralan) for chronic heart failure
2010 NIHR Horizon Scanning Centre (NIHR HSC) Linagliptin (Ondero) for type 2 diabetes mellitus - monotherapy or add-on therapy
2010 NIHR Horizon Scanning Centre (NIHR HSC) Panitumumab (Vectibix) metastatic and/or recurrent head and neck cancer - first line
2010 NIHR Horizon Scanning Centre (NIHR HSC) Panobinostat (Faridak) for relapsed or refractory classical Hodgkin's lymphoma - third line
2010 Finnish Office for Health Care Technology Assessment (Finohta) Management of infection in patients in health centres. Final report of the MIKSTRA programme
2010 NIHR Horizon Scanning Centre (NIHR HSC) Pegaptanib sodium (Macugen) for diabetic macular oedema
2010 NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) for recurrent or newly diagnosed metastatic head and neck cancer
2010 NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for prevention of venous thromboembolism in medically ill patients
2010 NIHR Horizon Scanning Centre (NIHR HSC) Tafamidis for transthyretin amyloid polyneuropathy
2010 NIHR Horizon Scanning Centre (NIHR HSC) Telaprevir (VX-950) for hepatitis C
2010 NIHR Horizon Scanning Centre (NIHR HSC) Tobramycin inhaled powder (TIP) for Pseudomonas aeruginosa infection in cystic fibrosis
2010 NIHR Horizon Scanning Centre (NIHR HSC) Zibotentan for metastatic castration resistant prostate cancer - first line
2010 NIHR Horizon Scanning Centre (NIHR HSC) Asenapine (Saphris) for manic episodes associated with bipolar l disorder
2010 NIHR Horizon Scanning Centre (NIHR HSC) Asenapine (Saphris) for schizophrenia
2010 NIHR Horizon Scanning Centre (NIHR HSC) Dapagliflozin (BMS 512148) for type 2 diabetes mellitus - add on therapy
2010 NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib plus paclitaxel for metastatic breast cancer - first line
2010 NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for venous thromboembolism
2010 NIHR Horizon Scanning Centre (NIHR HSC) Sunitinib for advanced and/or metastatic pancreatic neuroendocrine tumours
2010 NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for psoriatic arthritis - second line after disease modifying anti-rheumatic drugs (DMARDs)
2010 NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat for refractory multiple myeloma
2010 Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analaysis
2010 Belgian Health Care Knowledge Centre (KCE) Is neonatal screening for cystic fibrosis recommended in Belgium?
2010 Belgian Health Care Knowledge Centre (KCE) Remote monitoring for patients with implanted defibrillators. Technology evaluation and broader regulatory framework
2010 Committee for New Health Technology Assessment (CNHTA) [Silver in situ hybridization]